Morphic Therapeutic has lost Johnson & Johnson's Janssen Pharma as a partner, following the termination of an alliance to develop drugs targeting integrins first agreed in 2019. In a filing with ...

Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with ...

Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with ...

Investing in global listed securities screened to exclude entities involved in environmentally damaging activities (including coal and uranium, mining and oil and gas), intensive farming and ...

Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update. Morphic Ethical Equities Fund Ltd. held its Annual General Meeting, discussing key financial matters including an increase in ...

Eli Lilly has bolstered its inflammatory bowel disease (IBD) pipeline with a $3.2 billion bid to acquire Morphic and its mid-stage oral integrin therapy MORF-057. Lilly is launching a tender offer ...

Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update. Morphic Ethical Equities Fund Ltd. has announced an increase in their share buyback capacity to 20% of shares, totaling over 7.4 ...

The American pharmaceutical company Eli Lilly & Co. has entered into an agreement to acquire the biopharmaceutical company Morphic Holding Inc. This is reported in a press release Eli Lilly. The ...

all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Morphic Ethical Equities Fund Ltd. held its Annual General ...

Dr. Tipirneni most recently served as President and CEO of Morphic Therapeutics Inc. from company founding until the ...

Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Ellerston Capital Limited has become a substantial holder in Morphic Ethical Equities Fund Ltd ...